|
|
||||||||
From Marianne-Strauss-Klinik (W.P., W.F.), Berg; Therapiezentrum Burgau (L.-P.E.); and Department of Neurology (A.S.), University of Munich, Klinikum Grosshadern, Germany.
Address correspondence and reprint requests to Dr. Walter Pöllmann, Marianne-Strauss-Klinik, Milchberg 21, D- 82335, Berg, Germany; e-mail: Walter.Poellmann{at}ms-klinik.info
During the first 6 months of glatiramer acetate therapy in 82 consecutive patients with multiple sclerosis, in only 6% frequency of pre-existing headaches increased by more than 50%. This is less than the headache aggravation reported in an earlier study in up to 35% of patients during the first 6 months on interferon beta.
Additional material related to this article can be found on the Neurology Web site. Go to www.neurology.org and scroll down the Table of Contents for the January 24 issue to find the title link for this article.
Disclosure: The authors report no conflicts of interest.
Received March 28, 2005. Accepted in final form October 12, 2005.
This article has been cited by other articles:
![]() |
F Martinelli Boneschi, B Colombo, P Annovazzi, V Martinelli, L Bernasconi, C Solaro, and G Comi Lifetime and actual prevalence of pain and headache in multiple sclerosis Multiple Sclerosis, May 1, 2008; 14(4): 514 - 521. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |